Evoluderm Partners with NextStage AM in €27M Growth Investment to Fuel Global Expansion

Evoluderm, the French health and beauty brand renowned for offering quality personal care products at accessible prices, has entered a strategic minority partnership with NextStage AM, a Paris-based investment firm focused on supporting high-growth small and mid-sized companies. The €27 million capital investment marks a major milestone in Evoluderm’s ambitious growth trajectory, setting the stage for accelerated expansion both domestically and internationally.

Founded in 2004 by Nathalie and Gabriel Aiach, Evoluderm has carved out a strong position in the “mass premium” segment of the health and beauty sector. Over the past five years, the brand has significantly scaled its operations, now reaching more than 100 markets worldwide. Its revenue has tripled in the last three years, approaching €40 million in 2025, driven by a diversified portfolio and rapid consumer adoption.

Evoluderm’s success is rooted in its fully integrated value chain, which includes its own R&D laboratory, product development expertise, robust logistics, and expansive digital deployment. This integrated model enables the brand to launch over 30 product innovations annually and distribute more than 20 million units across a comprehensive range of around 250 items for face, body, and hair care. According to market research firm Kantar, Evoluderm ranks among the top brands for customer acquisition in its category.

Growth Investment to Power Expansion Plans

The capital infusion from NextStage AM will support Evoluderm’s strategic priorities:

• Widening its physical and digital distribution footprint in key markets across Europe and beyond.

• Reinforcing its brand identity and deepening emotional engagement with consumers to solidify “cult” status in competitive markets.

• Continued innovation in product quality and new launches while maintaining Evoluderm’s hallmark of affordability.

Michaël Strauss-Kahn, Partner at NextStage AM, highlighted Evoluderm’s distinctive market positioning, noting that the brand offers “a third way” in a sector polarized between complex premium beauty and budget options. He emphasized their confidence in Evoluderm’s ability to grow within the expanding mass-premium segment, where quality and accessibility are increasingly valued by consumers.

A Strategic Partnership with Shared Vision

NextStage AM brings extensive experience in capital development and support for growing enterprises. With nearly 25 years of investment activity and a diversified portfolio, the firm focuses on empowering management teams and fostering sustainable expansion through financial backing and strategic guidance.

Evoluderm’s founders, Nathalie and Gabriel Aiach, expressed optimism about the partnership’s potential to accelerate their vision. By combining Evoluderm’s agile innovation framework with NextStage AM’s investment expertise, the brand aims to capitalize on evolving consumer trends and strengthen its foothold in an increasingly competitive global beauty landscape.

As evolving beauty market dynamics continue to emphasize both quality and value, this strategic capital alliance positions Evoluderm to leverage its unique value proposition and scale its presence effectively across new markets.